TickerFactsScreenerDevelopers

Larimar Therapeutics, Inc. (LRMR) — Operating Income

Annual figures by fiscal year, from SEC filings.

2012: -$13.79M2013: -$13.78M2014: -$35.53M2015: -$73.81M2016: -$58.23M2017: -$53.00M2018: -$61.12M2019: -$23.21M2020: -$42.80M2021: -$50.47M2022: -$36.53M2023: -$41.76M2024: -$90.89M2025: -$172.50M-$172.50M
2012Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$172.50M-89.8%
2024-$90.89M-117.7%
2023-$41.76M-14.3%
2022-$36.53M+27.6%
2021-$50.47M-17.9%
2020-$42.80M-84.4%
2019-$23.21M+62.0%
2018-$61.12M-15.3%
2017-$53.00M+9.0%
2016-$58.23M+21.1%
2015-$73.81M-107.7%
2014-$35.53M-157.9%
2013-$13.78M+0.1%
2012-$13.79M—